SGP
SpyGlass Pharma, Inc.
34.97
+0.79 (+2.31%)
52w low 17.06
39.92 high
78.3% of range
Financial Analysis
| (USD) | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 14.23M | 27.06M | 41.45M | |
| R&D | 9.96M | 19.98M | 29.18M | |
| SG&A | 4.27M | 7.08M | 12.27M | |
| Operating Income | -14.23M | -27.06M | -41.45M | |
| EBITDA | -14.11M | -26.79M | -40.84M | |
| Pretax Income | -13.32M | -29.16M | -39.87M | |
| Income Tax | 0.00 | 0.00 | 0.00 | |
| Net Income | -13.32M | -29.16M | -39.87M | |
| EPS Diluted | -1.17 | -1.62 | -1.25 | |
| Diluted Shares | 11.40M | 17.96M | 31.91M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--